Inhibition of Pin1 in breast cancer tissue suppresses NF-κB activation (Ryo et al., 2003), suggesting Pin1 as a potential target for controlling aberrant NF-κB activation in cancer and related diseases. This evidence concerns the gene NFKB1 and breast carcinoma.